New paper reveals how the human immune system fights #malaria caused by Plasmodium vivax, opening new avenues to develop #vaccines against the most widespread form of malaria. Published in @cp-immunity.bsky.social
@burnetinstitute.bsky.social @wehi-research.bsky.social
doi.org/10.1016/j.im...
01.03.2026 21:36
π 4
π 2
π¬ 0
π 0
Those who know me, know Iβm not someone who changes his preferences & behaviors lightly. As Ron Swanson said, βI regret nothing. The end.β Well, let me tell you about our new study, out from The Perry Lab @mskcancercenter.bsky.social in @cp-immunity.bsky.social, which is the exception. /1
24.02.2026 23:56
π 17
π 4
π¬ 2
π 1
So glad that you had a good experience! β€οΈ Happy to see it out!
30.01.2026 17:07
π 1
π 0
π¬ 0
π 0
Stepwise epigenetic signal integration drives adaptive programming of cytotoxic lymphocytes
Lymphocyte differentiation during infection depends on the integration of antigen and cytokine signals, yet how the timing and sequence of these cues β¦
Excited to share my paper published today in @cp-immunity.bsky.social! We find that when CTLs integrate antigen and cytokine signaling, the timing of these cues matters - shedding light on an old question: Why do NK cells sometimes behave like CD8+ T cells?
www.sciencedirect.com/science/arti...
30.01.2026 16:00
π 18
π 7
π¬ 2
π 1
Commensal-derived trehalose monocorynomycolate triggers Ξ³Ξ΄ T cell-driven protective ocular barrier immunity: Immunity www.cell.com/immunity/ful... @cp-immunity.bsky.social
19.01.2026 16:07
π 6
π 4
π¬ 1
π 0
State-specific enhancer landscapes govern microglial plasticity @cp-immunity.bsky.social www.cell.com/immunity/ful...
07.01.2026 17:01
π 12
π 5
π¬ 0
π 0
Thrilled to share our new paper on reactive microglial plasticity! Using long-term fate mapping and epigenetic profiling, we uncover the remarkable plasticity of reactive microglia across the lifespan and the enhancers and associated TFs that govern state transitions.
07.01.2026 21:22
π 9
π 8
π¬ 1
π 0
So excited to share with you our latest work, result of my PhD with Dr.Rejane Rua at the @ciml.bsky.social! πΎ
If you want to brainstorm about bone channels and skullβs contribution to meningeal immunity, have a look! π¬π§
29.12.2025 15:59
π 16
π 7
π¬ 0
π 0
How is the persistence of compartmentalized inflammation sustained in MS?
Our new study in
@cp-immunity.bsky.social
offers some hints.
cell.com/immunity/ful...
Thanks and congratulations to all contributors
29.10.2025 15:01
π 17
π 11
π¬ 0
π 0
For those of you joining us for the editors panel at #RTN2025, please bring your questions! We have more editors than I've ever seen at a single meeting, so this is your chance to get answers to all of your burning questions! @genelayinstitute.bsky.social @rtnconference.bsky.social
15.10.2025 13:30
π 11
π 4
π¬ 0
π 0
Looking forward to #RTN2025 today! Excited for some #neuroimmunology! If you'll be there, please look for me and say hello! @genelayinstitute.bsky.social @rtnconference.bsky.social
genelayinstitute.org/rtn/#program
14.10.2025 14:25
π 14
π 3
π¬ 0
π 0
#CSNeuroimmune25 @danmucida.bsky.social
talking about food allergy and neuroimmune response to helminth infection @cp-neuron.bsky.social
08.09.2025 19:02
π 14
π 0
π¬ 0
π 0
Supplemental Video 2_Littleton et al_2025
YouTube video by Daniel R. Saban
#CSNeuroimmune25 Come learn about a novel neuro immune niche that underpins touch! Littleton Tues P2.38 13:00-14:30 youtu.be/BAtzNKj4wxA?siβ¦
07.09.2025 19:43
π 7
π 2
π¬ 0
π 0
Getting ready for #CSNeuroimmune25 tomorrow in NYC! Excited to see everyone, and looking forward to some cool #neuroimmunology! @cp-neuron.bsky.social @cp-immunity.bsky.social www.cell-symposia.com/neuroimmunol...
06.09.2025 23:39
π 18
π 3
π¬ 0
π 0
The high (I)COSt of costimulation for exhausted T cells
ICOS agonists are being investigated for cancer immunotherapy based on the idea that
they will reinvigorate exhausted CD8+ T cell anti-cancer immunity. Humblin et al.
unexpectedly find the oppositeβth...
It was a privilege and a pleasure for both myself and @menezesnmaria.bsky.social⬠to preview a great upcoming article in @cp-immunity.bsky.social⬠by @kamphorstlab.bsky.social⬠showing an unexpected inhibitory role for ICOS in exhausted CD8+ T cells.
www.cell.com/immunity/abs...
13.08.2025 11:33
π 17
π 5
π¬ 1
π 0
ScienceDirect.com | Science, health and medical journals, full text articles and books.
#ChromatinPower #WhatADay! After our paper @cp-immunity.bsky.social (free link π authors.elsevier.com/a/1lS0g3qNrU-iβ¦) happy for our tiny contribution to @xuzhoulab.bsky.social Medzhitov &co amazing paper @cp-cell.bsky.social showing pH controls inflammation via chromatin remodeling! Free linkπ
17.07.2025 21:06
π 8
π 2
π¬ 0
π 0
Early discounted registration ends June 27th for #CSNeuroimmune25, Sept 7β9, NYC! Explore cutting-edge #neuroimmunology and engage with experts in the field. Keynotes: David Julius & Susan Kaech hubs.li/Q03qS95l0 @cp-neuron.bsky.social @kavithascranton.bsky.social @cellpress.bsky.social
26.06.2025 18:20
π 4
π 1
π¬ 0
π 0
The R136S mutation in the APOE3 gene confers resilience against tau pathology via inhibition of the cGAS-STING-IFN pathway @cp-immunity.bsky.social www.cell.com/immunity/ful...
23.06.2025 20:07
π 19
π 7
π¬ 0
π 0
Cell Symposia
Explore breakthroughs in #cancer #immunology with global leaders.
#CellSymposia: The cancer-immunity cycle
Keynotes: Ira Mellman & Carl June
Abstract submission deadline: July 25
Sitges, Spain | Nov 2β4, 2025
http://dlvr.it/TLX7WS
24.06.2025 11:50
π 2
π 1
π¬ 0
π 0
So proud to share my first first-author paper from my postdoc in @liganlab.bsky.social out yesterday in
@cp-immunity.bsky.social! We characterized a model of the APOE3 Christchurch mutation on a tauopathy background and found downregulation of cGAS-STING-IFN pathway as a source of protection!
24.06.2025 18:04
π 29
π 8
π¬ 2
π 0
Meet the keynote speakers at #CSNeuroimmune25: David Julius (UCSF) & Susan Kaech (The Salk Institute) NYC | Sept 7β9, 2025 Early registration discount ends June 27!
hubs.li/Q03sQJjj0 @tcellogic.bsky.social @cp-neuron.bsky.social @salkinstitute.bsky.social #neuroimmune
20.06.2025 20:11
π 5
π 1
π¬ 0
π 0